Topic: Biotech
Dr. Tony Giordano, director of the Biotechnology program at LSU Bioscience Center, speaks with Dr. Moira Gunn about a brand new degree - a PhD in Biotech.
Eden BioDesign's CEO, Crawford Brown, speaks with Dr. Moira Gunn about how they help innovative ideas move out of the lab and into the biobusiness life-cycle.
Dr. Moira Gunn speaks with Dr. Ren Ee Chee about the focus of biotech in Singpore - from Dengue Fever to difficult strains of tuberculosis to bird flu.
Dr. Moira Gunn speaks with Patrick Kelly, VP of State Government Relations at the Biotechnology Industry Organization, about the state of biotech in the United States.
Dr. Jenny Harry, deputy CEO and Executive VP for Diagnostics at Proteome Systems, talks to Dr. Moira Gunn about a far more effective test for prostate cancer.
Dr. Una Ryan, President & CEO of Avant, speaks with Dr. Moira Gunn about their goals for making new vaccines.
Dr. Moira Gunn looks at a new way to take common drugs - a spray on the skin - by talking to Igor Gonda, the CEO of the Australian-based Acrux.
Nick Falk, Manager of Business Development from the Tasmanian firm Marinova, speaks with Dr. Moira Gunn about their application of marine biotech.
Robert Langer has been referred to as "a medical pioneer in the guise of an engineer" who has revolutionized the delivery of drugs and the engineering of human tissue. In this audio interview with Globeshakers host Tim Zak, Langer reveals his tenacious nature and talks about what it takes to persevere in the face of public criticism.
Dr. Moira Gunn talks with Phil Luton of the UK's Health Protection Agency about the first non-US research organization to be approved for biodefence and bioterrorism since the events of 9/11.
